Please login to the form below

Not currently logged in
Email:
Password:

pipelines

This page shows the latest pipelines news and features for those working in and with pharma, biotech and healthcare.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out

Shire's board of directors rejected the bid saying it "significantly undervalued the company, its growth prospects and pipeline”, but noted it has asked its advisors to discuss whether “a further, ... that has since been followed by at least 18 other

Latest news

More from news
Approximately 16 fully matching, plus 1,035 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    And while the pipeline of new drugs has slowly dwindled, resistance has been on the rise. ... While a new army of smaller biotechs is focusing on AMR innovation, to truly drive research forward and strengthen the dwindling global pipeline, big pharma

  • Health on instalment Health on instalment

    Although so far only a handful of treatments have been approved, an estimated 1, 500 crowd the pipeline, 40 or so of which appear ready for approval in the next few

  • Deal Watch January 2018

    Portfolio/pipeline in haemophilia and other rare blood disorders. Acquisition company. 11, 600. ... Acquisition company. 7, 000. Ablynx/Sanofi. Nanobody platform product pipeline; lead product caplacizumab for acquired thrombotic thrombocytopenic purpura

  • Drug pricing

    Healthcare terms - Drug pricing.

  • Drug R&D

    Healthcare terms - Drug R&D.

More from intelligence
Approximately 1 fully matching, plus 115 partially matching documents found.

Latest appointments

  • Celgene boosts CAR-T stake again with Bluebird Bio deal Celgene boosts CAR-T stake again with Bluebird Bio deal

    Mere weeks after completing its acquisition of CAR-T specialist Juno, Celgene has added to its cell therapy pipeline with another clinical-stage CAR-T candidate from Bluebird Bio. ... Celgene has been adding to its pipeline on all fronts of late, with

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    With expertise in corporate partnering, mergers and acquisitions, pipeline and product portfolio development, legal and IP strategy, Magovcevic-Liebisch has worked in several management roles including executive vice president and chief

  • Leo Pharma appoints new senior vice president Leo Pharma appoints new senior vice president

    We are serving more than 80 million patients worldwide, are launching several products and have an ambitious pipeline and Rhonda is the right person to continue to optimise our operations and

  • Therachon poaches Shire’s Aled Williams Therachon poaches Shire’s Aled Williams

    in developing TA-46, and advancing Therachon’s pipeline of drug candidates that aim to bring a transformational new therapy to those in the achondroplasia community.”.

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    His close engagement with emerging science across biotech and shared focus on patients brings valuable contributions to helping us advance our strategy and pipeline of transformational medicines.”.

More from appointments
Approximately 0 fully matching, plus 169 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 28 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics